QGAI
What one share of Quantum Genesis AI holds
Industrial Organic Chemicals
Quantumzyme Corp., is a biotransformation company, focused on clean and green chemistry. Specifically, Quantumzyme is in the business of developing engineered enzymes in the application of active pharmaceutical ingredients (“API”) production.
Quantum Genesis AI’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-04-30; the balance sheet is as of 2026-04-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.12 |
| Cash and investments | $0.00 |
| Debt | $0.01 |
| Book value | −$0.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.03 | −$0.00 | — | −$0.00 | — | $0.00 |
| 2018 | $0.02 | −$0.01 | $0.00 | −$0.00 | — | −$0.00 |
| 2024 | $0.00 | −$0.01 | — | −$0.00 | — | −$0.01 |
| 2025 | $0.00 | −$0.01 | — | −$0.00 | — | −$0.01 |